🔎 Trials Near Me

ホーム › 脳腫瘍 › テネシー

テネシーにおける脳腫瘍の臨床試験

テネシー内の拠点で、脳腫瘍に関する12件の研究が参加者を募集しています。

テネシー内の都市

公式研究テキスト(英語)

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Vanderbilt University Medical Center, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Sarah Canon Research Institute (SCRI) Oncology Partners, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

  • St. Jude Children's Research Hospital, Memphis
被験者募集中第2相
59 Months · 全性別 · 2026/09/15更新 · NCT05535166

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • SCRI Oncology Partners, Nashville
  • Vanderbilt Ingram Cancer Center, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • SCRI Oncology Partners, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05386108

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

  • CHI Memorial Hospital, CommonSpirit, Chattanooga
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/22更新 · NCT04427384

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

  • Vanderbilt University Medical Center, Nashville
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/07/01更新 · NCT07210632

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

  • Vanderbilt University Medical Center, Nashville
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/06/30更新 · NCT07493447

Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors

  • St. Jude Children's Research Hospital, Memphis
被験者募集中
8歳〜22歳 · 全性別 · 2026/06/17更新 · NCT05947045

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Baptist (BHMCC), Memphis
  • Vanderbilt-Ingram Cancer Center, Nashville
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

  • Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中早期第1相
18歳以上 · 全性別 · 2024/09/23更新 · NCT05996432

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。